All of the following are the actions of β–blockers in CHF except:
Decrease in mortality associated with CHF Antagonism of vasoconstriction due to sympathetic overactivity Prevention of pathological remodelling of ventricular myocardium Prevention of dangerous cardiac arrhythmias